Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Elucidation of bioinformatic-guided high-prospect drug repositioning candidates for DMD via Swanson linking of target-focused latent knowledge from text-mined categorical metadata

Frontiers in Cell and Developmental Biology(2023)10.3389/fcell.2023.1226707Source: DataRank Database

Elucidation of bioinformatic-guided high-prospect drug repositioning candidates for DMD via Swanson linking of target-focused latent knowledge from text-mined categorical metadata is a research paper published in Frontiers in Cell and Developmental Biology (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.14)OA: goldTopics (46)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Florian Barthélémy ORCID,Stanley F. Nelson ORCID,J. Wes Ulm ORCID

Live enrichment

PubMed:37664462 PMC:PMC10469615 OpenAlex:https://openalex.org/W4385932782

NHGRI NIH HHS

Grant: T32 HG002536

National Institutes of Health

Grant: 3T32HG002536-06S1

Training Grant in Genomic Analysis and Interpretation

FWCI

0.14

Citation Percentile

0.5%

Citation Trend

2025

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fcell.2023.1226707/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fcell.2023.1226707/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fcell.2023.1226707/full

journalhttps://doi.org/10.3389/fcell.2023.1226707

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37664462

Fields of Study

Computational Drug Discovery MethodsBioinformatics and Genomic NetworksBiomedical Text Mining and Ontologies

Keywords

Drug repositioningCategorical variableMetadataDrug discoveryComputational biologyDrugComputer scienceDrug targetInformation retrievalBioinformaticsWorld Wide WebMedicineBiologyMachine learningPharmacologyDMDTherapydata miningMeSHDrug RepurposingLatent KnowledgeSwanson LinkingDuchenne/ Becker Muscular DystrophyQH301-705.5610Duchenne/ Becker Muscular Dystrophy (rcdc)Rare Diseases (rcdc)Cell and Developmental BiologyRare Diseases61531 Biological sciences (for-2020)2.1 Biological and endogenous factorsMuscular DystrophyBiology (General)32 Biomedical and Clinical Sciences (for-2020)Pediatric (rcdc)PediatricBiomedical and Clinical Sciences2.1 Biological and endogenous factors (hrcs-rac)Biological SciencesOrphan DrugOrphan Drug (rcdc)Muscular Dystrophy (rcdc)

Sustainable Development Goals

SDG 0: Good health and well-being